Chagas disease in Spain, the United States and other non-endemic countries
Introduction
American trypanosomiasis or Chagas disease is a zoonosis endemic to Latin America that currently affects around 8–10 million people (Organización Panamericana De La Salud, 2006). Nearly 60 million people live in areas with vector-borne transmission risk and the disease causes an estimated 14,000 deaths per year (Schofield et al., 2006, Senior, 2007). Historically a disease of poor, rural populations, recent trends in migration have brought Trypanosoma cruzi infection to Latin American cities, and far beyond the borders of Latin America (Gurtler et al., 2003, Gascon, 2005).
Section snippets
The disease
Vectorial transmission of T. cruzi occurs only in endemic countries of the Western Hemisphere. The haematophagous triatomine insect vector deposits excreta containing the parasite on the host while taking a blood meal; inoculation of the parasite into the bite-wound, conjunctivae or mucus membranes can result in T. cruzi infection. Recently, oral transmission has been reported in several outbreaks (Dias et al., 2008). Other routes such as blood transfusion, organ transplants and vertical
Epidemiology in non-endemic countries
Chagas disease arrived in non-endemic countries with migrants from Latin America, and the epidemiology reflects differences in the origins of immigrants and distribution of the infection in their countries of birth. The United States continues to be the most common country of destination, but since tightening of U.S. immigration regulations after the attacks of 9/11/2001, the number of Latin American immigrants in Europe has more than doubled, from an estimated 910,402 in 2001 to more than 2
Chagas control in endemic countries and effect on the epidemiology in non-endemic countries
In Latin America, vector control and blood bank screening have greatly expanded in the last 15 years (Dias et al., 2002, Schofield et al., 2006). PAHO has certified elimination of T. cruzi transmission by domestic vectors in Uruguay (1997), Chile (1999) and Brazil (2006) (Schofield et al., 2006, Pan American Health Organization, 2006). Transmission has decreased substantially, leading to lower infection rates in children and young adults, and steep declines in the number of acute infections (
Chagas disease in non-endemic countries: current challenges
In the absence of vectorial transmission, congenital and blood-borne routes take on proportionately more importance. Several cases of congenital T. cruzi infection have been reported in Spain, and one in Switzerland (Muñoz et al., 2009, Muñoz et al., 2007, Riera et al., 2006, Flores-Chavez et al., 2008a, Jackson et al., 2008). Raising awareness of the potential for congenital T. cruzi transmission is of particular importance in Spain, where more than 60% of Latin American immigrants are women (
Future directions and research gaps
Because Chagas disease has only been recognized recently as a public health issue in non-endemic countries, health care providers and policy makers lack both technical knowledge and awareness of the disease. Better disease burden estimates will require better data on endemic country seroprevalence, as well as direct assessments in high risk populations in non-endemic countries. Rational strategies need to be developed for screening and control in blood banks, organ procurement agencies and for
Acknowledgements
We are grateful to Alessandro Bortoloni (Italy), Yves Jackson (Switzerland), Michel Develoux (France), and Jorge Seixas (Portugal) for providing demographic and health system data.
References (82)
Diagnosis and treatment of imported Chagas disease
Med. Clin. (Barc.)
(2005)- et al.
Diagnosis, management and treatment of chronic Chagas’ heart disease in areas where Trypanosoma cruzi infection is not endemic
Rev. Esp. Cardiol.
(2007) Epidemiology of Chagas disease in Mexico: an update
Trends Parasitol.
(2001)- et al.
Distribution and characterization of canine Chagas disease in Texas
Vet. Parasitol.
(2008) - et al.
Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas’ cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)
Am. Heart J.
(2008) - et al.
Prognostic impact of Chagas disease in the United States
Am. Heart J.
(2009) - et al.
Congenital Trypanosoma cruzi infection in a non-endemic area
Trans. R. Soc. Trop. Med. Hyg.
(2007) - et al.
Epidemiological surveillance of vertically-transmitted Chagas disease at three maternity hospitals in the Valencian Community
Enferm. Infecc. Microbiol. Clin.
(2008) Clinical and epidemiological aspects of Chagas disease
Lancet Infect. Dis.
(2001)- et al.
The future of Chagas disease control
Trends Parasitol.
(2006)
Chagas disease: moving towards global elimination
Lancet Infect. Dis.
Tracing of one year of Chagas screening at the Centro de Transfusion de Galicia (C.T.G.) concerning a positive blood donor, Regional Congress of the ISBT, Europe
Vox Sanguinis
Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection
Lancet
An estimate of the burden of Chagas disease in the United States
Clin. Infect. Dis.
Evaluation and treatment of Chagas disease in the United States: a systematic review
JAMA
Chagas disease and the US blood supply
Curr. Opin. Infect. Dis.
Mother-to-child transmission of Chagas’ disease in North America: why don’t we do more?
Matern. Child Health J.
A Situaçao Demografica Recente em Portugal
Revista de Estudos Demográficos
The costs of preventing and treating chagas disease in Colombia
PLoS Negl. Trop. Dis.
Transfusión sanguínea y enfermedad de Chagas: iniciativas en Centros de Transfusión de España
Enf. Emerg.
Chagas disease after organ transplantation—United States, 2001
MMWR Morb. Mortal. Wkly. Rep.
Chagas disease after organ transplantation—Los Angeles, California, 2006
MMWR Morb. Mortal. Wkly. Rep.
Blood donor screening for chagas disease—United States, 2006–2007
MMWR Morb. Mortal. Wkly. Rep.
Transfusion-associated Chagas’ disease in Texas: report of a case
Tex. Med.
Prevalence of antibody to Trypanosoma cruzi in pregnant Hispanic women in Houston
Clin. Infect. Dis.
The impact of Chagas disease control in Latin America: a review
Mem. Inst. Oswaldo Cruz
Acute Chagas disease outbreak associated with oral transmission
Rev. Soc. Bras. Med. Trop.
Autochthonous transmission of Trypanosoma cruzi, Louisiana
Emerg. Infect. Dis.
Laparoscopic-assisted rectosigmoidectomy with ileal loop interposition. Surgical treatment of chagasic megacolon
Dis. Colon Rectum
Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components
Off. J. Eur. Union
Fatal congenital Chagas’ disease in a non-endemic area: a case report
Cases J.
Transfusional chagas disease: parasitological and serological monitoring of an infected recipient and blood donor
Clin. Infect. Dis.
Chagas disease in a recipient of cord blood transplantation
Bone Marrow Transplant.
Control de la transmisión vertical de Trypanosoma cruzi en España: principal reto de la patología importada
Enferm. Infecc. Microbiol. Clin.
Congenital transmission of Trypanosoma cruzi infection in Argentina
Emerg. Infect. Dis.
Cited by (479)
Melatonin: A look at protozoal and helminths
2024, BiochimieParadigm shift in myocarditis treatment
2024, Journal of CardiologyDesign, synthesis and antitrypanosomatid activity of 2-nitroimidazole-3,5-disubstituted isoxazole compounds based on benznidazole
2023, European Journal of Medicinal ChemistryChagas Disease: a Review and Perspective on Laboratory Diagnostics in the United States
2023, Clinical Microbiology NewsletterSuccessful ablation of ventricular tachycardia in a patient with Chagas disease using ethanol ablation in the coronary venous system: A case report
2023, HeartRhythm Case ReportsCitation Excerpt :Chagas disease is a parasitic zoonosis which constitutes a severe public health problem and is endemic in 21 Latin American countries.1 It is estimated that between six and eight million people are infected with Trypanosoma cruzi (T cruzi), with an additional 65 million at risk of acquiring the disease by vector-borne transmission, blood or congenital transmission, or food-borne transmission.2,3 Chagas disease has both an acute, indeterminate, and chronic phase.